Phase 4 randomized, controlled study comparing sirolimus and mycophenolate mofetil to prevent or reverse progression in pediatric renal transplants with chronic allograft nephropathy.

Trial Profile

Phase 4 randomized, controlled study comparing sirolimus and mycophenolate mofetil to prevent or reverse progression in pediatric renal transplants with chronic allograft nephropathy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2010

At a glance

  • Drugs Sirolimus (Primary) ; Mycophenolate mofetil
  • Indications Renal transplant rejection
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Feb 2010 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
    • 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 05 May 2007 Interim results have been reported.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top